Výborná léčebná odpověď na pembrolizumab u 51letého nemocného s metastatickým uroteliálním karcinomem

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Excellent therapeutic response to pembrolizumab in a 51-year-old patient with metastatic urothelial carcinoma
Authors

BOŠANSKÁ Barbora VARGA Gabriel EID Michal SAID Dávid FEDORKO Michal

Year of publication 2025
Type Article in Periodical
Magazine / Source Česká urologie
MU Faculty or unit

Faculty of Medicine

Citation
web https://czechurol.cz/artkey/cur-202501-0007_vyborna_lecebna_odpoved_na_pembrolizumab_u_51leteho_nemocneho_s_metastatickym_urotelialnim_karcinomem.php
Doi http://dx.doi.org/10.48095/cccu2025008
Keywords imunotherapy; pembrolizumab; next-generation sequencing; urothelial carcinoma
Description The authors present a case report of a patient suffered from metastatic urothelial carcinoma and discuss the role and efficacy of pembrolizumab in the context of comprehensive genomic profiling of tumor tissue.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info